IL155178A0 - Use of chemokine mutants in multiple sclerosis, some such new mutants and their preparation - Google Patents
Use of chemokine mutants in multiple sclerosis, some such new mutants and their preparationInfo
- Publication number
- IL155178A0 IL155178A0 IL15517801A IL15517801A IL155178A0 IL 155178 A0 IL155178 A0 IL 155178A0 IL 15517801 A IL15517801 A IL 15517801A IL 15517801 A IL15517801 A IL 15517801A IL 155178 A0 IL155178 A0 IL 155178A0
- Authority
- IL
- Israel
- Prior art keywords
- mutants
- preparation
- multiple sclerosis
- chemokine
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00121665 | 2000-10-04 | ||
PCT/EP2001/011428 WO2002028419A2 (en) | 2000-10-04 | 2001-10-03 | Chemokine mutants in the treatment of multiple sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
IL155178A0 true IL155178A0 (en) | 2003-11-23 |
Family
ID=8170011
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15517801A IL155178A0 (en) | 2000-10-04 | 2001-10-03 | Use of chemokine mutants in multiple sclerosis, some such new mutants and their preparation |
IL155178A IL155178A (en) | 2000-10-04 | 2003-04-01 | Use of Kamokin mutants to prepare a drug for the treatment of multiple sclerosis, such new mutants and their preparation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL155178A IL155178A (en) | 2000-10-04 | 2003-04-01 | Use of Kamokin mutants to prepare a drug for the treatment of multiple sclerosis, such new mutants and their preparation |
Country Status (31)
Country | Link |
---|---|
US (1) | US7402303B2 (ko) |
EP (1) | EP1326628B1 (ko) |
JP (1) | JP3908165B2 (ko) |
KR (1) | KR100837898B1 (ko) |
CN (1) | CN1285381C (ko) |
AR (1) | AR030854A1 (ko) |
AT (1) | ATE265222T1 (ko) |
AU (2) | AU2002215919B2 (ko) |
BG (1) | BG66137B1 (ko) |
BR (1) | BR0114407A (ko) |
CA (1) | CA2423616C (ko) |
CZ (1) | CZ303409B6 (ko) |
DE (1) | DE60103078T2 (ko) |
DK (1) | DK1326628T3 (ko) |
EA (1) | EA006137B1 (ko) |
EE (1) | EE05174B1 (ko) |
ES (1) | ES2217199T3 (ko) |
HK (1) | HK1062811A1 (ko) |
HR (1) | HRP20030215B1 (ko) |
HU (1) | HUP0302194A3 (ko) |
IL (2) | IL155178A0 (ko) |
MX (1) | MXPA03003008A (ko) |
NO (1) | NO330278B1 (ko) |
PL (1) | PL204231B1 (ko) |
PT (1) | PT1326628E (ko) |
RS (1) | RS50738B (ko) |
SI (1) | SI1326628T1 (ko) |
SK (1) | SK287523B6 (ko) |
UA (1) | UA77950C2 (ko) |
WO (1) | WO2002028419A2 (ko) |
ZA (1) | ZA200302315B (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005525089A (ja) | 2001-12-17 | 2005-08-25 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | ケモカイン・アンタゴニストとして作用するケモカイン突然変異体 |
DE60303929T2 (de) * | 2002-04-04 | 2006-08-10 | Applied Research Systems Ars Holding N.V. | Chemokin-muntanten mit verbesserter oraler bioverfügbarkeit |
WO2004062688A2 (en) * | 2002-12-23 | 2004-07-29 | Applied Research Systems Ars Holding N.V. | Use of cc-chemokine mutants against liver diseases |
DE602004018014D1 (de) * | 2003-10-22 | 2009-01-08 | Serono Lab | Cxcl8-antagonisten |
AT412785B (de) * | 2003-12-04 | 2005-07-25 | Kungl Andreas J Dr | Gag-bindungsproteine |
DE60304435T2 (de) * | 2004-01-19 | 2006-08-24 | Ares Trading S.A. | Verfahren zur Reinigung von in Bakterien exprimierten Proteinen |
GB0412400D0 (en) * | 2004-06-03 | 2004-07-07 | Univ Newcastle | Treatment of inflammatory conditions |
EP1760110B1 (en) * | 2005-09-03 | 2011-11-02 | Samsung SDI Co., Ltd. | Polybenzoxazine-based compound, electrolyte membrane including the same, and fuel cell employing the electrolyte membrane |
GB0614755D0 (en) | 2006-07-25 | 2006-09-06 | Univ Geneve | Cytokine derivatives |
MX2010001307A (es) | 2007-08-02 | 2010-07-30 | Novimmune Sa | Anticuerpos anti-proteína regulada con la activación, expresada y secretada por los linfocitos t normales y metodos de uso de los mismos. |
AU2011213559B2 (en) * | 2010-02-08 | 2015-05-07 | The Trustees Of The University Of Pennsylvania | Nucleic acid molecules encoding RANTES, and compositions comprising and methods of using the same |
CA3101052A1 (en) | 2018-05-28 | 2019-12-05 | ORION Biotechnology Switzerland Sarl | Methods of inhibiting cerebral inflammation |
WO2022093857A1 (en) * | 2020-10-26 | 2022-05-05 | City Of Hope | Oncolytic virus compositions and methods for the treatment of cancer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5739103A (en) * | 1993-11-12 | 1998-04-14 | Dana-Farber Cancer Institute | Chemokine N-terminal deletion mutations |
WO1998006751A1 (en) * | 1996-08-16 | 1998-02-19 | Research Corporation Technologies, Inc. | Mcp-3, rantes and mip-1alpha receptor antagonists |
EP0906954A1 (en) * | 1997-09-29 | 1999-04-07 | Applied Research Systems ARS Holding N.V. | Amino-terminal truncated c-c chemokines as chemokine antagonist |
DE69832216T2 (de) * | 1997-12-23 | 2006-05-24 | Fondazione Centro San Raffaele Del Monte Tabor | RANTES-Mutanten und therapeutische Anwendungen davon |
AU2740900A (en) * | 1999-01-29 | 2000-08-18 | Millennium Pharmaceuticals, Inc. | Method of treating demyelinating inflammatory disease using ccr1 antagonists |
-
2001
- 2001-03-10 UA UA2003044038A patent/UA77950C2/uk unknown
- 2001-10-03 AT AT01986265T patent/ATE265222T1/de active
- 2001-10-03 PT PT01986265T patent/PT1326628E/pt unknown
- 2001-10-03 PL PL362350A patent/PL204231B1/pl not_active IP Right Cessation
- 2001-10-03 AU AU2002215919A patent/AU2002215919B2/en not_active Ceased
- 2001-10-03 KR KR1020037004599A patent/KR100837898B1/ko not_active IP Right Cessation
- 2001-10-03 EP EP01986265A patent/EP1326628B1/en not_active Expired - Lifetime
- 2001-10-03 WO PCT/EP2001/011428 patent/WO2002028419A2/en active IP Right Grant
- 2001-10-03 EA EA200300439A patent/EA006137B1/ru not_active IP Right Cessation
- 2001-10-03 HU HU0302194A patent/HUP0302194A3/hu unknown
- 2001-10-03 CA CA2423616A patent/CA2423616C/en not_active Expired - Fee Related
- 2001-10-03 DK DK01986265T patent/DK1326628T3/da active
- 2001-10-03 MX MXPA03003008A patent/MXPA03003008A/es active IP Right Grant
- 2001-10-03 EE EEP200300139A patent/EE05174B1/xx not_active IP Right Cessation
- 2001-10-03 ES ES01986265T patent/ES2217199T3/es not_active Expired - Lifetime
- 2001-10-03 ZA ZA200302315A patent/ZA200302315B/en unknown
- 2001-10-03 DE DE60103078T patent/DE60103078T2/de not_active Expired - Lifetime
- 2001-10-03 JP JP2002532243A patent/JP3908165B2/ja not_active Expired - Fee Related
- 2001-10-03 BR BR0114407-3A patent/BR0114407A/pt not_active IP Right Cessation
- 2001-10-03 AU AU1591902A patent/AU1591902A/xx active Pending
- 2001-10-03 CN CNB018199178A patent/CN1285381C/zh not_active Expired - Fee Related
- 2001-10-03 CZ CZ20030947A patent/CZ303409B6/cs not_active IP Right Cessation
- 2001-10-03 US US10/398,457 patent/US7402303B2/en not_active Expired - Fee Related
- 2001-10-03 SK SK406-2003A patent/SK287523B6/sk not_active IP Right Cessation
- 2001-10-03 RS YUP-257/03A patent/RS50738B/sr unknown
- 2001-10-03 SI SI200130130T patent/SI1326628T1/xx unknown
- 2001-10-03 IL IL15517801A patent/IL155178A0/xx unknown
- 2001-10-04 AR ARP010104684A patent/AR030854A1/es unknown
-
2003
- 2003-03-20 HR HR20030215A patent/HRP20030215B1/xx not_active IP Right Cessation
- 2003-03-28 BG BG107685A patent/BG66137B1/bg unknown
- 2003-04-01 IL IL155178A patent/IL155178A/en not_active IP Right Cessation
- 2003-04-03 NO NO20031525A patent/NO330278B1/no not_active IP Right Cessation
-
2004
- 2004-08-02 HK HK04105657A patent/HK1062811A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001253456A1 (en) | Antithrombogenic membrane mimetic compositions and methods | |
EP1414841A4 (en) | Oligonucleotide-containing pharmaceutical compositions and their use | |
IL155178A0 (en) | Use of chemokine mutants in multiple sclerosis, some such new mutants and their preparation | |
ZA978089B (en) | 3,4-diaryloxazolone derivatives, their methods of preparation, and their use in therapeutics. | |
AU1334602A (en) | Osteopontin-coated surfaces and methods of use | |
AU4209301A (en) | Chair and table assembly | |
AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
HUP0400262A3 (en) | Glycopeptides, their preparation and use in the treatment of multiple sclerosis | |
HK1072948A1 (en) | Ifnar2 mutants, their production and use | |
AU8975701A (en) | Novel composition and use | |
AU3283299A (en) | Probiotic composition and the use thereof | |
AU2001236001A1 (en) | Immune enhancement compositions and use thereof | |
AU5104101A (en) | Composition and use | |
AU2001269106A1 (en) | Novel alpha expressed in heart and testis | |
HUP0201800A2 (en) | Novel calpains and their use | |
HUP0104267A3 (en) | 1,4-diaryl-2-fluoro-1-buten-3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiane and 1,4-diaryl-2-fluoro-2-butene compounds | |
GB0014191D0 (en) | Use and combined preparation | |
AU2002220047A1 (en) | Novel fish chemokine and methods for use | |
AU5025801A (en) | Novel polypeptide---a human hexose kinase 13 and polynucleotide encoding it | |
TW422022U (en) | Assembled table and chair | |
AU2002212046A1 (en) | Novel polypeptide--- the human cytokine receptor 13.31 and polynucleotide encoding it | |
SI1379639T1 (sl) | Misja glukoronil C5-epimeraza, DNA, ki kodira le-to, in njena uporaba | |
GB0002560D0 (en) | Virulence gene and protein and their use | |
GB0003726D0 (en) | Virulence gene and protein and their use | |
GB0002557D0 (en) | Virulence gene and protein and their use |